Literature DB >> 28934428

HIV-Infected Children Have Elevated Levels of PD-1+ Memory CD4 T Cells With Low Proliferative Capacity and High Inflammatory Cytokine Effector Functions.

Julia Foldi1, Lina Kozhaya2, Bret McCarty1,3, Mussa Mwamzuka4, Fatma Marshed4, Tiina Ilmet1,3, Max Kilberg1,3, Adam Kravietz1,5, Aabid Ahmed4, William Borkowsky1,3, Derya Unutmaz1,5, Alka Khaitan1,3,5.   

Abstract

Background: During human immunodeficiency virus (HIV) disease, chronic immune activation leads to T-cell exhaustion. PD-1 identifies "exhausted" CD8 T cells with impaired HIV-specific effector functions, but its role on CD4 T cells and in HIV-infected children is poorly understood.
Methods: In a Kenyan cohort of vertically HIV-infected children, we measured PD-1+ CD4 T-cell frequencies and phenotype by flow cytometry and their correlation with HIV disease progression and immune activation. Second, in vitro CD4 T-cell proliferative and cytokine responses to HIV-specific and -nonspecific stimuli were assessed with and without PD-1 blockade.
Results: HIV-infected children have increased frequencies of PD-1+ memory CD4 T cells that fail to normalize with antiretroviral treatment. These cells are comprised of central and effector memory subsets and correlate with HIV disease progression, measured by viral load, CD4 percentage, CD4:CD8 T-cell ratio, and immune activation. Last, PD-1+ CD4 T cells predict impaired proliferative potential yet preferentially secrete the Th1 and Th17 cytokines interferon-γ and interleukin 17A, and are unresponsive to in vitro PD-1 blockade. Conclusions: This study highlights differences in PD-1+ CD4 T-cell memory phenotype and response to blockade between HIV-infected children and adults, with implications for potential immune checkpoint therapies.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV infection; PD-1+ CD4 T cells; Th17; children; immune exhaustion

Mesh:

Substances:

Year:  2017        PMID: 28934428      PMCID: PMC5853680          DOI: 10.1093/infdis/jix341

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  34 in total

1.  The generation of Th memory in neonates versus adults: prolonged primary Th2 effector function and impaired development of Th1 memory effector function in murine neonates.

Authors:  B Adkins; Y Bu; P Guevara
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

2.  Factors influencing T cell activation and programmed death 1 expression in HIV-infected children.

Authors:  Andrew Prendergast; Maria O'Callaghan; Esse Menson; Djamel Hamadache; Sam Walters; Nigel Klein; Philip Goulder
Journal:  AIDS Res Hum Retroviruses       Date:  2011-09-07       Impact factor: 2.205

Review 3.  T cell exhaustion.

Authors:  E John Wherry
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

4.  Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation.

Authors:  Fusheng Li; Uma Malhotra; Peter B Gilbert; Natalie R Hawkins; Ann C Duerr; Juliana M McElrath; Lawrence Corey; Steven G Self
Journal:  Vaccine       Date:  2006-06-27       Impact factor: 3.641

5.  Differential impact of PD-1 and/or interleukin-10 blockade on HIV-1-specific CD4 T cell and antigen-presenting cell functions.

Authors:  Filippos Porichis; Meghan G Hart; Jennifer Zupkosky; Lucie Barblu; Douglas S Kwon; Ashley McMullen; Thomas Brennan; Rafi Ahmed; Gordon J Freeman; Daniel G Kavanagh; Daniel E Kaufmann
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

6.  Phenotype, function, and gene expression profiles of programmed death-1(hi) CD8 T cells in healthy human adults.

Authors:  Jaikumar Duraiswamy; Chris C Ibegbu; David Masopust; Joseph D Miller; Koichi Araki; Gregory H Doho; Pramila Tata; Satish Gupta; Michael J Zilliox; Helder I Nakaya; Bali Pulendran; W Nicholas Haining; Gordon J Freeman; Rafi Ahmed
Journal:  J Immunol       Date:  2011-03-07       Impact factor: 5.422

7.  Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy.

Authors:  Cynthia L Gay; Ronald J Bosch; Justin Ritz; Jason M Hataye; Evgenia Aga; Randall L Tressler; Stephen W Mason; Carey K Hwang; Dennis M Grasela; Neelanjana Ray; Josh C Cyktor; John M Coffin; Edward P Acosta; Richard A Koup; John W Mellors; Joseph J Eron
Journal:  J Infect Dis       Date:  2017-06-01       Impact factor: 5.226

8.  The Distribution and Immune Profile of T Cell Subsets in HIV-Infected Children from Uganda.

Authors:  Isaac Ssewanyana; Chris A R Baker; Theodore Ruel; Stephanie Bousheri; Moses Kamya; Grant Dorsey; Philip J Rosenthal; Edwin Charlebois; Diane Havlir; Huyen Cao
Journal:  AIDS Res Hum Retroviruses       Date:  2009-01       Impact factor: 2.205

9.  Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction.

Authors:  Daniel E Kaufmann; Daniel G Kavanagh; Florencia Pereyra; John J Zaunders; Elizabeth W Mackey; Toshiyuki Miura; Sarah Palmer; Mark Brockman; Almas Rathod; Alicja Piechocka-Trocha; Brett Baker; Baogong Zhu; Sylvie Le Gall; Michael T Waring; Ryan Ahern; Kristin Moss; Anthony D Kelleher; John M Coffin; Gordon J Freeman; Eric S Rosenberg; Bruce D Walker
Journal:  Nat Immunol       Date:  2007-09-30       Impact factor: 25.606

10.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.

Authors:  Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

View more
  11 in total

1.  Subcutaneous Adipocyte Adenosine Triphosphate Levels in HIV Infected Patients.

Authors:  Greg S Gojanovich; Cecilia M Shikuma; Cris Milne; Daniel E Libutti; Dominic C Chow; Mariana Gerschenson
Journal:  AIDS Res Hum Retroviruses       Date:  2019-09-17       Impact factor: 2.205

Review 2.  CD4 T-Cell Exhaustion: Does It Exist and What Are Its Roles in Cancer?

Authors:  Alexandra M Miggelbrink; Joshua D Jackson; Selena J Lorrey; Ethan S Srinivasan; Jessica Waibl-Polania; Daniel S Wilkinson; Peter E Fecci
Journal:  Clin Cancer Res       Date:  2021-06-14       Impact factor: 12.531

3.  T cell immune discriminants of HIV reservoir size in a pediatric cohort of perinatally infected individuals.

Authors:  Stefano Rinaldi; Lesley de Armas; Sara Dominguez-Rodríguez; Suresh Pallikkuth; Vinh Dinh; Li Pan; Kathleen Gӓrtner; Rajendra Pahwa; Nicola Cotugno; Pablo Rojo; Eleni Nastouli; Nigel Klein; Caroline Foster; Anita De Rossi; Carlo Giaquinto; Paolo Rossi; Paolo Palma; Savita Pahwa
Journal:  PLoS Pathog       Date:  2021-04-26       Impact factor: 6.823

4.  PD-1 Expression on Mycobacterium tuberculosis-Specific CD4 T Cells Is Associated With Bacterial Load in Human Tuberculosis.

Authors:  Cheryl L Day; Deborah A Abrahams; Rubina Bunjun; Lynnett Stone; Marwou de Kock; Gerhard Walzl; Robert J Wilkinson; Wendy A Burgers; Willem A Hanekom
Journal:  Front Immunol       Date:  2018-08-31       Impact factor: 7.561

5.  Immune Protection of SIV Challenge by PD-1 Blockade During Vaccination in Rhesus Monkeys.

Authors:  Enxiang Pan; Fengling Feng; Pingchao Li; Qing Yang; Xiuchang Ma; Chunxiu Wu; Jin Zhao; Hongbin Yan; Rulei Chen; Ling Chen; Caijun Sun
Journal:  Front Immunol       Date:  2018-10-23       Impact factor: 7.561

6.  HBV and HIV/HBV Infected Patients Have Distinct Immune Exhaustion and Apoptotic Serum Biomarker Profiles.

Authors:  Mohamed Tarek M Shata; Enass A Abdel-Hameed; Susan D Rouster; Li Yu; Meina Liang; Esther Song; Mark T Esser; Norah Shire; Kenneth E Sherman
Journal:  Pathog Immun       Date:  2019-02-13

Review 7.  Biological Aging and Immune Senescence in Children with Perinatally Acquired HIV.

Authors:  Annalisa Dalzini; Maria Raffaella Petrara; Giovanni Ballin; Marisa Zanchetta; Carlo Giaquinto; Anita De Rossi
Journal:  J Immunol Res       Date:  2020-05-16       Impact factor: 4.818

8.  Prediction of PD-L1 inhibition effects for HIV-infected individuals.

Authors:  Valerya Zheltkova; Jordi Argilaguet; Cristina Peligero; Gennady Bocharov; Andreas Meyerhans
Journal:  PLoS Comput Biol       Date:  2019-11-06       Impact factor: 4.475

9.  Categorisation of patients based on immune profiles: a new approach to identifying candidates for response to checkpoint inhibitors.

Authors:  Svetlana Bornschlegl; Michael P Gustafson; Danae A Delivanis; Mabel Ryder; Minetta C Liu; George Vasmatzis; Chris L Hallemeier; Sean S Park; Lewis R Roberts; Ian F Parney; Diane F Jelinek; Allan B Dietz
Journal:  Clin Transl Immunology       Date:  2021-04-29

10.  Altered Expression of CD300a Inhibitory Receptor on CD4+ T Cells From Human Immunodeficiency Virus-1-Infected Patients: Association With Disease Progression Markers.

Authors:  Joana Vitallé; Iñigo Terrén; Leire Gamboa-Urquijo; Ane Orrantia; Laura Tarancón-Díez; Miguel Genebat; Ezequiel Ruiz-Mateos; Manuel Leal; Susana García-Obregón; Olatz Zenarruzabeitia; Francisco Borrego
Journal:  Front Immunol       Date:  2018-07-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.